This study explored the clinical and economic impact of clinical pharmacological advice (CPA) [based on therapeutic drug monitoring (TDM) results, and on patients' characteristics and co-medications] on personalized linezolid therapy in a tertiary-care hospital.

A 1 year retrospective audit of quality indicators of clinical pharmacological advice for personalized linezolid dosing: one stone for two birds?

PEA, Federico;BARALDO, Massimo
2016

Abstract

This study explored the clinical and economic impact of clinical pharmacological advice (CPA) [based on therapeutic drug monitoring (TDM) results, and on patients' characteristics and co-medications] on personalized linezolid therapy in a tertiary-care hospital.
File in questo prodotto:
File Dimensione Formato  
Br J Clin Pharmacol 812 341 348.pdf

non disponibili

Descrizione: ARTICOLO PRINCIPALE
Tipologia: Versione Editoriale (PDF)
Licenza: Non pubblico
Dimensione 949.41 kB
Formato Adobe PDF
949.41 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11390/1070839
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 13
  • ???jsp.display-item.citation.isi??? 14
social impact